Clinical development of two innovative pharmaceutical forms of leuprorelin acetate

机译：醋酸亮丙瑞林的两种创新药物形式的临床开发

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives:Two innovative pharmaceutical forms of leuprorelin acetate have been developed as 1-month and 3-month implants for the treatment of advanced hormone-dependent prostate cancer. These products contain active substance dispersed homogeneously in a biodegradable polymer. Here we present the key results from the clinical development of these slow-release implant formulations of leuprorelin.

机译：目的：已开发出两种创新的醋酸亮丙瑞林药物形式，分别用于治疗晚期激素依赖性前列腺癌的1个月和3个月植入物。这些产品包含均匀分散在可生物降解聚合物中的活性物质。在这里，我们介绍了亮丙瑞林这些缓释植入物配方临床开发的关键结果。

著录项

期刊名称 Therapeutic Advances in Urology
作者
Goetz Geiges; Elisabeth Schapperer; Ursula Thyroff-Friesinger; Zoltán Vendel Engert; Patricia Gravel;
展开▼
作者单位

展开▼
年(卷),期 2013(5),1
年度 2013
页码 3–10
总页数 8
原文格式 PDF
正文语种
中图分类泌尿科学（泌尿生殖系疾病）;小儿泌尿科学;肾疾病;
关键词
implant luteinizing hormone-releasing hormone agonists prostate cancer;

机译：植入物;促黄体激素释放激素激动剂;前列腺癌;

相似文献

外文文献
中文文献
专利

1. Clinical development of two innovative pharmaceutical forms of leuprorelin acetate [J] . Goetz Geiges, Elisabeth Schapperer, Ursula Thyroff-Friesinger, Therapeutic advances in urology. . 2013,第1期

机译：醋酸亮丙瑞林的两种创新药物形式的临床开发
2. Testosterone suppression with a unique form of leuprorelin acetate as a solid biodegradable implant in patients with advanced prostate cancer: results from four trials and comparison with the traditional leuprorelin acetate microspheres formulation [J] . Mladen Solari?, Anders Bjartell, Ursula Thyroff-Friesinger, Therapeutic advances in urology. . 2017,第6期

机译：独特形式的醋酸亮丙瑞林作为固体可生物降解植入物可抑制晚期前列腺癌患者的睾丸激素：四项试验的结果，并与传统醋酸亮丙瑞林微球制剂进行比较
3. Two innovative pharmaceutical forms of leuprorelin: results from 818 patients with advanced prostate cancer. [J] . Patricia Gravel, Dirk Samland, Martin L?ffler, Advances in therapy. . 2013,第3期

机译：亮丙瑞林的两种创新药物形式：来自818名晚期前列腺癌患者的结果。
4. Formation and development of pharmaceutical clusters as an innovative activity of territories [C] . Alexander Vladimirovich Evstratov, Oleg Nikolaevich Pushkarev, Tatyana Anatolyevna Oleynikova, International Scientific-Practical Conference on Business Cooperation . 2019

机译：制药集群作为领土的创新活动的形成与发展
5. Pharmaceutical research and development: A key informant assessment of whether an "open-science" model could improve clinical research in terms of quality and efficiency. [D] . King, Timothy D. N. 2013

机译：药物研究与开发：关于“开放科学”模型是否可以改善临床研究的质量和效率的一项重要信息评估。
6. Testosterone suppression with a unique form of leuprorelin acetate as a solid biodegradable implant in patients with advanced prostate cancer: results from four trials and comparison with the traditional leuprorelin acetate microspheres formulation [O] . Mladen Solarić, Anders Bjartell, Ursula Thyroff-Friesinger, 2017

机译：独特形式的醋酸亮丙瑞林作为可生物降解的固体植入物抑制睾丸激素：晚期前列腺癌患者的四项试验结果以及与传统醋酸亮丙瑞林微球制剂的比较
7. Testosterone suppression with a unique form of leuprorelin acetate as a solid biodegradable implant in patients with advanced prostate cancer : results from four trials and comparison with the traditional leuprorelin acetate microspheres formulation [O] . Solarić, Mladen, Bjartell, Anders, Thyroff-Friesinger, Ursula, 2017

机译：在晚期前列腺癌患者中使用独特形式的醋酸亮丙瑞林作为固体可生物降解植入物抑制睾酮：来自四项试验的结果和与传统醋酸亮丙瑞林微球制剂的比较
8. Innovative Development of Evidence-Based, Medical Evacuation Clinical Practice Guidelines and Novel Validation of the Current Critical Care Air Transport Team Clinical Practice Guideline. [R] . Petro, M., Rodriquez, D., Fowler, J., 2018

机译：基于证据的医疗后送临床实践指南的创新发展和当前重症监护航空运输团队临床实践指南的新颖验证。

Clinical development of two innovative pharmaceutical forms of leuprorelin acetate

摘要

著录项

相似文献

相关主题

期刊订阅